medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2022, Number 05

<< Back Next >>

Ginecol Obstet Mex 2022; 90 (05)

Pituitary apoplexy during pregnancy: A case report

Martínez-Villafaña E, Almanza-Mackintoy A, Charua-Levy E

Language: Spanish
References: 19
Page: 443-447
PDF size: 371.16 Kb.


ABSTRACT

Background: Pituitary apoplexy is a sudden infarction or hemorrhage in a tumor or healthy tissue of the pituitary gland. Eighty percent of cases are in patients with a pituitary adenoma. The clinical picture is characterized by headache, visual disturbances, nausea and vomiting, and pituitary insufficiency, which can be life-threatening for the mother and fetus. Conservative treatment includes analgesics, corticosteroids and dopaminergic agonists in case of prolactinoma. The surgical treatment of choice is transsphenoidal resection.
Clinical case: 35-year-old female patient with a history of three pregnancies, one miscarriage and prolactinoma diagnosed at 22 years of age, under treatment with cabergoline. She came for consultation due to headache at 17 weeks of pregnancy that was exacerbated at 28.4 weeks. Magnetic resonance imaging showed that the pituitary gland measured 17 x 12 x 7 mm, with evidence of subacute hemorrhage; based on this, a diagnosis of pituitary apoplexy was made. Conservative treatment with nonsteroidal anti-inflammatory drugs, opioids and corticosteroids was indicated; however, due to the deterioration of the clinical picture, endoscopic transseptal-transsphenoidal resection of the pituitary adenoma was decided at 30.5 weeks of pregnancy. The patient showed significant improvement and remained asymptomatic until the end of pregnancy at 37.5 weeks.
Conclusions: Although pituitary apoplexy is of low incidence in pregnancy, it becomes a risk factor for death; therefore, the obstetrician/gynecologist should be aware of the possible implications in pregnancy, offer multidisciplinary care and consider that surgical treatment is a safe option in pregnancy.


REFERENCES

  1. Nawar RN, Abdel Mannan D, Selman WR, Arafah BM. Pituitary Tumor Apoplexy: A Review. J Intensive Care Med 2008; 23 (2): 75-90. https://doi:10.1177/0885066607312992

  2. Petersenn S, Christ-Crain M, Droste M, Finke R, et al. Pituitary disease in pregnancy: special aspects of diagnosis and treatment? Geburtsh Frauenheilk 2019; 79 (4): 365-74. https://doi:10.1055/a-0794-7587

  3. Jemel M, Kandara H, Riahi M, Gharbi R, et al. Gestational pituitary apoplexy: Case series and review of the literature. J Gynecol Obstet Hum Reprod 2019; 48 (10): 873-81. https://doi:10.1016/j.jogoh.2019.05.005

  4. Grand´Maison S, Weber F, Bédard MJ, Mahone M, et al. Pituitary apoplexy in pregnancy: A case series and literature review. Obstet Med 2015; 8 (4): 177-83. https:// doi:10.1177/1753495X15598917

  5. Dinc H, Esen F, Demirci A, Sari A, et al. Pituitary dimensions and volume measurements in pregnancy and postpartum. Acta Radiol 1998; 39 (1): 64-9. https:// doi:10.1080/02841859809172152

  6. Gonzalez JG, Elizondo G, Saldivar D, Nanez H, et al. Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 1988; 85 (2): 217-20. https://doi:10.1016/s0002-9343(88)80346-2

  7. Karaca Z, Tanriverdi F, Unluhizarci K, Kelestimur F. Pregnancy and pituitary disorders. Eur J Endocrinol 2010; 162 (3): 453-75. https://doi:10.1530/EJE-09-0923

  8. Glezer A, Bronstein MD. Pituitary apoplexy: pathophysiology, diagnosis and management. Arch Endocrinol Metab 2015; 59 (3): 259-64. https://doi:10.1590/2359- 3997000000047

  9. Randeva HS, Schoebel J, Byrne J, Esiri M, et al. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf) 1999; 51 (2): 181-8. https:// doi:10.1046/j.1365-2265.1999.00754.x

  10. Geissler F, Hoesli I, Bernasconi MT, et al. Recurrent pituitary apoplexy in pregnancy. BMJ 2021; 14: e242353. https:// doi:10.1136/bcr-2021-242353

  11. Bamfo JEAK, Sharif S, Donnelly T, Cohen MA, et al. A case of pituitary apoplexy masquerading as hyperemesis gravidarum. J Obstet Gynaecol 2011; 31 (7): 662. https://doi:1 0.3109/01443615.2011.590911

  12. Rajasekaran S, Vanderpump M, Baldeweg S, Drake W, et al. UK guidelines for the management of pituitary apoplexy Pituitary Apoplexy Guidelines Development Group. Clin Endocrinol (Oxf) 2011; 74 (1): 9-20. https://doi:10.1111/ j.1365-2265.2010.03913.x

  13. Piantanida E, Gallo D, Lombardi V, Tanda ML, et al. Pituitary apoplexy during pregnancy: a rare, but dangerous headache. J Endocrinol Invest 2014; 37 (9): 789-97. https:// doi:10.1007/s40618-014-0095-4

  14. Capatina C, Inder W, Karavitaki N, Wass JAH, et al. Management of endocrine disease: Pituitary tumour apoplexy. European Journal of Endocrinology 2015; 172 (5): 179-90. https://doi:10.1530/eje-14-0794

  15. Krupp P, Monka C. Bromocriptine in pregnancy: safety aspects. Klin Wochenschr 1987; 65 (17): 823-7. https:// doi:10.1007/BF01727477

  16. Ricci E, Parazzini F, Motta T, Ferrari CI, et al. Pregnancy outcome after cabergoline treatment in early weeks of gestation. Reprod Toxicol 2002; 16 (6): 791-3. https:// doi:10.1016/s0890-6238(02)00055-2

  17. Lebbe M, Hubinont C, Bernard P, Maiter D. Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women. Clin Endocrinol (Oxf) 2010; 73: 236-42. https://doi:10.1111/j.1365- 2265.2010.03808.x

  18. Wang AT, Mullan RJ, Lane MA, Hazem A, et al. Treatment of hyperprolactinemia: a systematic review and meta-analysis. Syst Rev 2012; 24 (1): 33. https://doi:10.1186/2046- 4053-1-33

  19. Ciric I, Ragin A, Baumgartner C, Pierce D. Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 1997; 40 (2): 225-36. https://doi:10.1097/00006123- 199702000-00001




2020     |     www.medigraphic.com